Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins

被引：22

作者：

Arish, N.

Eldor, R.

Fellig, Y.

Bogot, N.

Laxer, U.

Izhar, U.

Rokach, A.

机构：

[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Inst Pulmonol, IL-91120 Jerusalem, Israel

[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Med C, IL-91120 Jerusalem, Israel

[3] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel

[4] Hebrew Univ Jerusalem, Hadassah Med Ctr, Inst Radiol, IL-91120 Jerusalem, Israel

[5] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Cardiothorac Surg, IL-91120 Jerusalem, Israel

来源：

THORAX | 2006年 / 61卷 / 12期

关键词：

D O I：

10.1136/thx.2004.029819

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Lymphocytic interstitial pneumonia ( LIP) is a rare form of interstitial lung disease. A few case reports have described an association with common variable immunodeficiency (CVID). Corticosteroids are usually used to treat symptomatic patients but their efficacy has never been studied in a controlled trial. We describe a patient with LIP and CVID who was treated monthly with intravenous immunoglobulins ( IVIG) without steroids. The patient improved dramatically. We believe that, in selected cases of LIP and immunodeficiency, IVIG given monthly should be considered as the only treatment without adding steroids.

引用

页码：1096 / 1097

页数：2

共 6 条

[1] Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency [J].